Biosensing systems for the detection of biomarkers of neurodegenerative diseases: A reviewTALANTAIF6.12025-03-010PRE
Preliminary studies on changes in the amount of tryptophan metabolites in human glioma tissuesANALYTICA CHIMICA ACTAIF62024-10-011OAAI
Phospho-Tau 181 quantification method for Alzheimer's disease based on an array 2D biosensor combined with surface plasmon resonance imagingTALANTAIF6.12024-05-013PRE
Comparison of Fluidic and Non-Fluidic Surface Plasmon Resonance Biosensor Variants for Angular and Intensity Modulation MeasurementsSENSORSIF3.52023-12-180OAAI
An Array SPRi Biosensor for the Determination on PARP-1 in Blood PlasmaBIOMEDICINESIF3.92023-02-172OAAI
An Immunosensor for the Determination of Cortisol in Serum and Saliva by Array SPRiSENSORSIF3.52022-12-107OAAI
Cathepsin B, D and S as Potential Biomarkers of Brain Glioma MalignancyJOURNAL OF CLINICAL MEDICINEIF2.92022-11-156OAAI
Laminin-5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma MalignancyBIOMEDICINESIF3.92022-09-156OAAI
Studies of interactions between fibronectin and a specific antibody against fibronectin using SPRi and QCMJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12022-04-015PRE
Two SPRi biosensors for the determination of cathepsin S in blood plasmaTALANTAIF6.12021-04-0110PREAI
Levels of Selected Matrix Metalloproteinases-MMP-1, MMP-2 and Fibronectin in the Saliva of Patients Planned for Endodontic Treatment or Surgical ExtractionJOURNAL OF CLINICAL MEDICINEIF2.92020-12-075OAAI
Spectroscopic, Zeta-potential and Surface Plasmon Resonance analysis of interaction between potential anti-HIV tannins with different flexibility and human serum albuminCOLLOIDS AND SURFACES B-BIOINTERFACESIF5.62020-10-0128PREAI